IL41868A - Pharmaceutical preparations containing d-penicillamine - Google Patents

Pharmaceutical preparations containing d-penicillamine

Info

Publication number
IL41868A
IL41868A IL41868A IL4186873A IL41868A IL 41868 A IL41868 A IL 41868A IL 41868 A IL41868 A IL 41868A IL 4186873 A IL4186873 A IL 4186873A IL 41868 A IL41868 A IL 41868A
Authority
IL
Israel
Prior art keywords
composition
composition according
penicillamine
compositions
tablet
Prior art date
Application number
IL41868A
Other versions
IL41868A0 (en
Original Assignee
Degussa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2214814A external-priority patent/DE2214814A1/en
Priority claimed from DE19722233993 external-priority patent/DE2233993A1/en
Application filed by Degussa filed Critical Degussa
Publication of IL41868A0 publication Critical patent/IL41868A0/en
Publication of IL41868A publication Critical patent/IL41868A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof

Abstract

1424432 Compositions containing synthetic D-penicillamine DEUTSCHE GOLD-UND SILBER - SOHEIDEANSTALT 23 March 1973 [25 March 1972 11 July 1972] 14158/73 Heading A5B [Also in Division C2] A pharmaceutical composition comprises fully synthetic D-penicillamine obtained by resolution of a D, L-penicillamine derivative of general formula: in which Ac represents an acyl group, Z represents H or together with Ac represents a diacyl radical, R represents H, a benzyl radical or an acyl group and R<SP>1</SP> and R<SP>2</SP> which may be the same or different, each represent H, C 1 -C<SP>8</SP> alkyl or a cycloalkyl or aryl radical, with an optically active base and converting the D-isomer obtained to D-penicillamine, together with at least one pharmaceutically acceptable additive or excipient. The compositions may be made up in forms suitable for oral, parenteral, rectal, vaginal or local administration or may be in the form of an inhalation. The compositions may contain other active ingredients such as analgesics, antihistamines, antiphlogistics, spasmolytics, geriatics, liver therapeutics, vitamins, trace elements and steroids. In examples salicylamide, α-tocopherol and ascorbic acid may be present. [GB1424432A]

Claims (1)

1. IS CLAIMED A medicinal composition containing completely synthetic or a pharmaceutically acceptable salt thereof and a pharmacologically acceptable said composition having less allergenic and side effects than a comparable composition containing natural A medicinal composition according to claim 1 including the disodium salt of tetraacetic A composition according to claim 2 including at least one of the following pharmaceutical a alginic calcium pectic di or tricalcium calcium cellulose sodium carboxymethyl gum gum vinyl acetate high magnesium ethylene solid or cetyl alcohol and hard fat having a hydroxy1 number of 1 to A composition in accordance with claim 1 in the form of a tablet or composition according to claim wherein the tablet or capsule has a gastric juice soluble A composition according to claim wherein the coating comprises an alkyl cellulose or hydroxyalkyl A composition according to claim 4 wherein the tablet or capsule has a gastric juice resistant A composition according to claim 7 wherein the coating comprises acylated A composition accordin to claim 1 comprising or a pharmaceutically acceptable salt thereof together with at least one non toxic solvent which is a partial ether of a polyhydric alcohol and a lower alkanolj a partial ester of a polyhydric alcohol with a lower aliphatic carboxylic an aliphatic carbonamide having 1 to 10 carbon atoms or an aliphatic A composition prepared from the composition of claim 1 and A suppository comprising the composition claim 1 and a hard A salve containing the composition of claim A composition according to l A composition according to claim 1 wherein the or salt thereof is formed by racemate a completely synthetically produced derivative of the where R is benzyl or and Ac is an group and and are of 1 to 8 carbon aryl or and Z stands for a hydrogen or together Ac may be a diacyl especially phthaly with an optically active A composition to claim wherein the derivative is or and the base is or A composition according to claim 14 wherein Ac is nitrophenyl or lower 34 A process for preparation of compositions acoarding to any one of to the la granulated vith known solid in the of a solu ion essentially of For insufficientOCRQuality
IL41868A 1972-03-25 1973-03-25 Pharmaceutical preparations containing d-penicillamine IL41868A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2214814A DE2214814A1 (en) 1972-03-25 1972-03-25 Synthetic d-penicillamine prepns - useful against fibrosis polyarthritis aggressive hepatitis etc
DE19722233993 DE2233993A1 (en) 1972-07-11 1972-07-11 Synthetic D-penicillamine prepns - obtd by optical resolution

Publications (2)

Publication Number Publication Date
IL41868A0 IL41868A0 (en) 1973-05-31
IL41868A true IL41868A (en) 1976-02-29

Family

ID=25762971

Family Applications (1)

Application Number Title Priority Date Filing Date
IL41868A IL41868A (en) 1972-03-25 1973-03-25 Pharmaceutical preparations containing d-penicillamine

Country Status (5)

Country Link
FR (1) FR2182892B1 (en)
GB (1) GB1424432A (en)
IL (1) IL41868A (en)
NL (1) NL7304113A (en)
OA (1) OA04527A (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2304055C3 (en) * 1973-01-27 1982-04-29 Degussa Ag, 6000 Frankfurt Process for the production of D-penicillamine
DE2304054C3 (en) * 1973-01-27 1982-04-08 Degussa Ag, 6000 Frankfurt Process for obtaining D-penicillamine
ATE73995T1 (en) * 1985-06-08 1992-04-15 Asta Medica Ag USE OF PENICILLAMIN TO TREAT IMMUNE DEFICIENCY DISEASES.
ES2739352T3 (en) 2009-02-26 2020-01-30 Glaxo Group Ltd Pharmaceutical formulations comprising 4 - {(1R) -2 - [(6- {2 - [(2,6-dichlorobenzyl) oxy] ethoxy} hexyl) amino] -1-hydroxyethyl} -2- (hydroxymethyl) phenol
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
WO2019111193A1 (en) * 2017-12-09 2019-06-13 Kashiv Pharma Llc A stable pharmaceutical composition comprising penicillamine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1015108A (en) * 1946-03-22 1952-08-27 Merck & Co Inc Process for the preparation of penicillin derivatives and products resulting therefrom
BE786964A (en) * 1971-07-30 1973-01-29 Degussa PROCEDURE FOR OBTAINING D-PENICILLAMINE

Also Published As

Publication number Publication date
IL41868A0 (en) 1973-05-31
FR2182892B1 (en) 1976-11-05
OA04527A (en) 1980-03-30
NL7304113A (en) 1973-09-27
AU5367973A (en) 1974-09-26
GB1424432A (en) 1976-02-11
FR2182892A1 (en) 1973-12-14

Similar Documents

Publication Publication Date Title
HUT50631A (en) Process for producing long-acting pharmaceutical compositions comprising etodolac active ingredient
IE39898B1 (en) 1-or 7-oxoalkyl xanthine derivatives
IL75337A (en) Polyenoic acids omega-substituted by a 4,5-dimethoxy-2-methyl-quinone or a 4,5-dimethoxy-2-methyl-phenyl group,process for the preparation thereof and pharmaceutical compositions containing the same
ES8404184A1 (en) 1-, and 1,1-disubstituted-6-substituted-2-carbamimidoyl-1-carbadethiapen-2-em-3-carboxylic acids, a process for preparing and an antibiotic composition containing the same.
ES2001706A6 (en) Peptide derivatives, process for the production thereof and pharmaceutical compositions containing same.
GB1476827A (en) Vincaminic acid esters
IE44942L (en) Piperazine and piperidine derivatives
ES465906A1 (en) Prolonged-release pharmaceutical compositions for oral administration, their methods of making and use
ES461399A1 (en) Epinine esters and pharmaceutical compositions thereof
IL41868A (en) Pharmaceutical preparations containing d-penicillamine
IE821796L (en) Waterless thixotropic composition
GB1285400A (en) Esters of substituted anthranilic acid
ES427079A1 (en) Phenothiazine derivatives, compositions thereof and methods of preparation thereof
ES484718A1 (en) Chromanol derivatives, a process for their preparation and pharmaceutical compositions comprising them.
WO1991018606A3 (en) Orally active nonaddicting analgesics
ES380859A1 (en) Dibenzo(d,g)(1,3)dioxocin-6-carboxylic acids, esters and salts
NL183186C (en) Process for the preparation of amino acid derivatives and of pharmaceutical compositions containing them, and pharmaceutical articles thus obtained.
GB1530074A (en) Rho-acetamidophenol derivatives the preparation thereof and the use of such derivatives as therapeutic agents
ES444926A1 (en) 3-thiolated-7-acylamido-cephalosporanic acid derivatives processes for preparing them and pharmaceutical compositions 0mprising them
ES471993A1 (en) Derivatives of pentacyclic alcaloids, method for their preparation, application in the synthesis of products of the eburnamonine group and pharmaceutical compositions.
GB1194505A (en) Piperidinol Derivatives and Process for Preparing Them
CA2136071A1 (en) 2-arylpropionic acid compositions and process for preparing the same
ES435604A1 (en) Indolylacetylamino acid derivatives, process for their preparation, and pharmaceutical compositions
GB1300419A (en) New morphinone derivatives and their preparation
IL38650A (en) N-acyl-(piperazinoalkyl)-pyrazoles and their preparation